glp 1 hospitalization Impact of glp-1 receptor agonists on for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study | Clinical Research in Cardiology The Many Cardiovascular Benefits of

Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation

Treatment with GLP-1RA downregulates NF-B activation in hepatic tissue, thereby leading to decreased transcription of cytokines and chemokines that sustain inflammation (23, 24)

Recent data from the ATTAIN-MAINTAIN trial showed that patients transitioning to orforglipron after injectable GLP-1 therapy maintained their weight loss with minimal regain (approximately 0.9 kg after semaglutide transition), suggesting that oral maintenance strategies could minimize the lean mass depletion seen with prolonged high-dose injectable therapy

2) that supports its involvement in acute opioid withdrawal in humans

S2CID 42538820